Industry sponsorship bias in cost effectiveness analysis: registry based analysis

22 June 2022 - The Tufts Cost-Effectiveness Analysis Registry was used to identify all CEAs published in Medline between 1976 and ...

Read more →

Givlaari is included in the high-cost protection with limitation

17 June 2022 - Givlaari (givosiran) is included in the high-cost protection with limited subsidy to reduce attacks in patients with ...

Read more →

EFPIA and Vaccines Europe are deeply disappointed about the decision taken by World Trade Organization at the Ministerial Conference to endorse a TRIPS waiver for COVID-19 vaccines

17 June 2022 - Speaking about the waiver, EFPIA Director General, Nathalie Moll said. “The decision is a serious retrograde step ...

Read more →

PHARMAC's latest breast cancer drug funding 'way short' - advocate

16 June 2022 - On Wednesday PHARMAC announced $190 million to fund cancer treatments and other medicines. ...

Read more →

IP waiver for COVID vaccines is a threat to future innovation

20 June 2022 - The decision to waive intellectual property protections for COVID-19 vaccines is fundamentally flawed and will have ...

Read more →

EU HTA regulation: international preparatory meeting in Cologne

17 June 2022 - At the invitation of IQWiG, 41 envoys from European HTA organisations and two from the EU ...

Read more →

Drug pricing debate in Washington is a headache for pharma

17 June 2022 - Last-ditch effort by Democrats to pass slimmed-down version of Build Back Better could include measures on drug ...

Read more →

Current issues in health technology assessment of cancer therapies: a survey of stakeholders and opinion leaders in Australia

17 June 2022 - The aim of this study was to find ways of bridging the gap in opinions concerning health ...

Read more →

Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb

14 June 2022 - Two prominent Democratic lawmakers are requesting that the Federal Trade Commission investigate whether price hikes for ...

Read more →

Canadian regulator OKs Hugel's botulinum toxin product

16 June 2022 - Hugel said Thursday that it has obtained product approval from Health Canada for its botulinum toxin ...

Read more →

Canadian drug prices: new regulations could save billions of dollars

15 June 2022 - New drug price regulations set to come into effect next month could lower spending on patented ...

Read more →

Start of rolling review for adapted Spikevax COVID-19 vaccine

17 June 2022 - EMA has started a rolling review for a version of Spikevax adapted to provide better protection ...

Read more →

Moderna receives FDA authorisation for emergency use of its COVID-19 vaccine for children 6 months of age and older

17 June 2022 - mRNA-1273 has been administered to millions of children and adolescents over the age of 6 worldwide, ...

Read more →

Pfizer-BioNTech COVID-19 vaccine receives FDA emergency use authorisation for children 6 months through 4 years of age

17 June 2022 - In a Phase 2/3 clinical trial, the Pfizer-BioNTech COVID-19 vaccine elicited a strong immune response in this ...

Read more →

Sierra Oncology announces submission of new drug application for momelotinib to US Food & Drug Administration

17 June 2022 - Submission seeks approval of momelotinib for the treatment of myelofibrosis. ...

Read more →

NICE recommends new targeted treatment for early breast cancer

16 June 2022 - NICE has provisionally approved a new treatment for early breast cancer that it says will benefit ...

Read more →